Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphaël Genolet

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Drug Targets. Inflammation and Allergy|December 9, 2004
PPARs as drug targets to modulate inflammatory responses?Raphaël Genolet, Walter Wahli, Liliane Michalik
Journal of Immunology (Baltimore, Md. : 1950)|August 25, 2010
Definition of key variables for the induction of optimal NY-ESO-1-specific T cells in HLA transgene miceAlexandre Johannsen, Raphaël Genolet, Daniel F Legler, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2014
Duality of the murine CD8 compartmentRaphaël Genolet, Julie Leignadier, Magne Østerås, et al.
Biosensors & Bioelectronics|March 12, 2017
Label-free identification of activated T lymphocytes through tridimensional microsensors on chipEnrica Rollo, Enrico Tenaglia, Raphaël Genolet, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2012
CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoireJohan Verhagen, Raphaël Genolet, Graham J Britton, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 9, 2012
KAP1 regulates gene networks controlling T-cell development and responsivenessFrancesca R Santoni de Sio, Isabelle Barde, Sandra Offner, et al.
Immunity|April 6, 2023
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopesJulien Racle, Philippe Guillaume, Julien Schmidt, et al.
Nature Communications|September 29, 2025
Neuron-reactive KIR<sup>+</sup>CD8<sup>+</sup> T cells display an encephalitogenic transcriptional program in autoimmune encephalitisSylvain Perriot, Samuel Jones, Raphaël Genolet, et al.
Science Advances|June 27, 2025
Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancerMargaux Saillard, Mara Cenerenti, Patrick Reichenbach, et al.
Science Advances|February 27, 2021
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancerAmélie Cachot, Mariia Bilous, Yen-Cheng Liu, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Drug Targets. Inflammation and Allergy|December 9, 2004
PPARs as drug targets to modulate inflammatory responses?Raphaël Genolet, Walter Wahli, Liliane Michalik
Journal of Immunology (Baltimore, Md. : 1950)|August 25, 2010
Definition of key variables for the induction of optimal NY-ESO-1-specific T cells in HLA transgene miceAlexandre Johannsen, Raphaël Genolet, Daniel F Legler, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2014
Duality of the murine CD8 compartmentRaphaël Genolet, Julie Leignadier, Magne Østerås, et al.
Biosensors & Bioelectronics|March 12, 2017
Label-free identification of activated T lymphocytes through tridimensional microsensors on chipEnrica Rollo, Enrico Tenaglia, Raphaël Genolet, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2012
CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoireJohan Verhagen, Raphaël Genolet, Graham J Britton, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 9, 2012
KAP1 regulates gene networks controlling T-cell development and responsivenessFrancesca R Santoni de Sio, Isabelle Barde, Sandra Offner, et al.
Immunity|April 6, 2023
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopesJulien Racle, Philippe Guillaume, Julien Schmidt, et al.
Nature Communications|September 29, 2025
Neuron-reactive KIR<sup>+</sup>CD8<sup>+</sup> T cells display an encephalitogenic transcriptional program in autoimmune encephalitisSylvain Perriot, Samuel Jones, Raphaël Genolet, et al.
Science Advances|June 27, 2025
Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancerMargaux Saillard, Mara Cenerenti, Patrick Reichenbach, et al.
Science Advances|February 27, 2021
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancerAmélie Cachot, Mariia Bilous, Yen-Cheng Liu, et al.
Pageof 1